Website        What is FOP       News         About IFOPA        Natural History Study       Contact Us 
Clementia Advances Natural History Study of FOP - Now Enrolling Patients Ages 2 to 65 years old

Posted May 28, 2015


The IFOPA is pleased to share news that Clementia Pharmaceuticals Natural History Study of patients with Fibrodysplasia Ossificans Progressiva (FOP) has commenced enrollment in the second part (Part B).


Part B will enroll 40 patients from two to 65 years of age. To download and read the entire announcement please click on Clementia NHS Study Update Release May 2015.


To help you learn more, click on our Clementia FOP Natural History Study website page for an informational video, Frequently Asked Questions and access a direct government link.


Please click on IFOPA's Clinical Trial Latest News to read information about the ongoing palovarotene clinical trial.


Questions? Please email them to
Like us on Facebook   Follow us on Twitter